Additional Alport Syndrome data presented at the ASN Kidney Week In late October, Daniel Gale, Professor of Nephrology at University College London Department of Renal Medicine, presented additional ...
DURHAM, N.C., Nov. 08, 2024 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology platform company developing universally implantable, bioengineered human tissue at ...